|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC Pharmaceuticals in Europe |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2006 |
Taille du document : |
14 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
1 520,00 €
|
| |
| |
OTC Pharmaceuticals in China
151 pages | Novembre 2002 |
This new report on the market for over-the-counter (OTC) pharmaceuticals in the People’s Republic of China.
The report covers the following sectors: Analgesics, Cough, cold and allergy (hay-fever) |
1 065,00 €
|
| |
| |
US First Aid 2004
16 pages | Juillet 2004 |
Snapdata's US First Aid 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US first aid market, and covers trea |
240,00 €
|
| |
| |
US Mineral Supplements 2004
12 pages | Novembre 2004 |
Snapdata's US Mineral Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US mineral supplement mark |
240,00 €
|
| |
| |
UK Analgesics 2004
12 pages | Juillet 2004 |
Snapdata's UK Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK analgesic market, and covers non |
240,00 €
|
| |
| |
US Family Planning 2004
12 pages | Novembre 2004 |
Snapdata's US Family Planning 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US family planning market, and |
240,00 €
|
| |
| |
Poland Contraceptives 2004
12 pages | Juillet 2004 |
Snapdata's Poland Contraceptives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the Polish contraceptive market |
240,00 €
|
| |
| |
US Acne Treatments 2004
14 pages | Juillet 2004 |
Snapdata's US Acne Treatments 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US acne treatments market.
|
240,00 €
|
| |
| |
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players
87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
2 443,75 €
|
| |
| |
US Cough Cold & Throat Remedies 2004
16 pages | Juillet 2004 |
Snapdata's US Cough Cold & Throat Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cough, cold an |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Pharmaceuticals in Europe |
|
|
Datamonitor's OTC Pharmaceuticals in Europe industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Scope
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and leading companies
* Includes a five-year forecast of the industry
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by both value and volume
* Market shares are covered by manufacturer and/or brand
* Distribution channels are also analyzed
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Competitive Landscape 13
CHAPTER 7 Leading Companies 14
7.1 GlaxoSmithKline Plc 14
7.2 Pfizer Inc 14
7.3 Sanofi-Aventis Group 15
CHAPTER 8 Distribution 16
CHAPTER 9 Market Forecasts 17
9.1 Market Value Forecast 17
CHAPTER 10 Macroeconomic Indicators 18
CHAPTER 11 Further Reading 19
11.1 Sources 19
11.2 Related Datamonitor Research 19
LIST OF TABLES
Table 1: Europe OTC Pharmaceuticals Market Value: $ billion, 2000-2004 9
Table 2: Europe OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2004 10
Table 3: Europe OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2004 11
Table 4: Europe OTC Pharmaceuticals Market Share: % Share, by Value, 2004 12
Table 5: Europe OTC Pharmaceuticals Distribution: % Share, by Value, 2004 16
Table 6: Europe OTC Pharmaceuticals Market Value Forecast: $ billion, 2004-2009 17
Table 7: Europe Exchange Rate, 2000 18
CONTENTS
|
|
|
PPLSEN
|
|
|
|
|
